7.1.3.7	  Risk-adapted treatment for clinical stage I non-seminomatous germ cell tumour based on vascular   invasion,
Recommendations,Strength rating
"Inform patients about all management options after orchidectomy: surveillance, adjuvant   chemotherapy, and retroperitoneal lymph node dissection, including treatment-specific   recurrence rates as well as acute and long-term side effects.",Strong
Offer surveillance or risk-adapted treatment based on lymphovascular invasion (see below).,Strong
"Discuss one course of cisplatin, etoposide, bleomycin as an adjuvant treatment alternative   in patients with stage I non-seminomatous germ cell tumour if patients are not willing to   undergo or comply with surveillance.",Strong
